Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
7.15
-0.27 (-3.64%)
At close: Aug 15, 2025, 1:18 PM

Mersana Therapeutics Revenue

Mersana Therapeutics reported an annual revenue of $40.5M, reflecting a 9.88% growth. For the quarter ending June 30, 2025, Mersana Therapeutics generated $3.06M in revenue.
Revenue (ttm)
40.5M
Revenue Growth
9.88%
Price / Sales Ratio
4.33
Revenue / Employee
397.03K
Employees
102
Market Cap
35.64M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.